MHRA consults on reclassification of Ibusol lotion from POM to P

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

NeLM news service

MHRA consults on reclassification of Ibusol lotion from POM to P

Source: MHRA

Date published: 03/02/2011 16:36

Summary

by: Yuet Wan

The MHRA is consulting on the reclassification of Ibusol lotion from Prescription Only Medicine (POM) to Pharmacy (P). Comments should received by 17 March 2011.

About this library entry

Category: 10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices | Law/ medical ethics/ litigation | Medicines and Healthcare products Regulatory Agency (MHRA) | OTC medicines | Prescribing and supply of medicines

NeLM area: News

Link

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.

Printer Friendly Version

Related evidence

10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices

09/03/2012

AWMSG issues Final Appraisal Recommendation on capsaicin 8% patch (Qutenza®) for peripheral neuropathic pain in non-diabetic patients

14/10/2011

NETAG issues recommendation on capsaicin cutaneous patch (Qutenza®) for neuropathic pain

07/02/2011

SMC accepts capsaicin cutaneous patch (Qutenza®) for restricted use